Immitra Bio
immitrabio.com
Actively hiring
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$2.7M
1 round on record
Latest round
$2.7M
Venture round · Aug 2026 · 1 mo ago
Backers
1
Occident
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2026 | $2.7M | Backbone Ventures and lead | ggba.swiss |
Backed byfrom the funds' portfolios and accelerator catalogs
Occident Similar startupsby what they do, their industry and backers
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of…
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.
Financials
Total raised
$2.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $2.7M | Details |